Identification of Proteins Involved in Airway Remodeling in Human Lung Fibroblasts
1 Kyla

Geary, MS and 1Farzaneh Daghigh, Ph.D.

Philadelphia College of Osteopathic Medicine, Department of Bio-Medical Sciences and Primary Care Medicine,
4170 City Avenue, Philadelphia, PA, 19131 and Center for Chronic Disorders of Aging, PCOM

INTRODUCTION
Asthma is an inflammatory disease associated with chronic
perturbation of homeostatic mechanisms, leading to
alterations in the structure of the airway walls, termed
airway remodeling (AR). Lung fibrosis is characterized by
increased deposition of extracellular matrix (ECM) proteins,
especially collagens, and enhanced proliferation and
activation of fibroblasts, and, ultimately, distortion of
normal lung architecture and loss of respiratory function.
L-arginine is a key precursor of nitric oxide and proline, an
amino acid enriched in collagen. Arginase, which converts Larginine into L-ornithine and urea, is a key enzyme of the
urea cycle in the liver, but it is also expressed in cells and
tissues that lack a complete urea cycle, including the lung.
Arginase exists as two distinct isoenzymes, arginase I and II,
which are encoded by different genes. Arginase I isoenzyme
is a cytosolic enzyme and is the predominant isoform in the
liver, where it is highly expressed [3]. Even though low
levels of arginase II have been detected in liver as well [4],
this mitochondrial enzyme is mainly expressed in
extrahepatic tissue [3].
Arginase isoenzymes and the downstream enzymes ornithine
decarboxylase (ODC) and ornithine aminotransferase (OAT)
are key regulators of critical processes associated with
asthma including AR, cell hyperplasia and collagen deposition
and have been implicated in the hyperplastic and fibrotic
changes of AR, respectively.
One of the biological functions of arginase II may be
regulation of the synthesis of nitric oxide (NO) by means of
competition with NO synthase (NOS) for the common
substrate, L-arginine (Figure 1). In addition, extrahepatic
arginase may be involved in tissue repair processes through
the synthesis of L-ornithine. Thus, L-ornithine is a precursor
of polyamines and L-proline, which are involved in cell
proliferation and collagen synthesis, respectively [3,5].

Figure 1: L-arginine metabolism and its role in asthma
airway remodeling
RESEARCH POSTER PRESENTATION DESIGN © 2012

www.PosterPresentations.com

Cell Culture

METHODS

RESULTS

Normal and diseased asthmatic human lung fibroblasts were purchased
from Lonza. Cells were cultured in Dulbecco’s Modified Eagle Medium
(Cellgro) containing 10% FBS. Passages 2-15 were used.

Cell Lysis and Protein Quantification
1 x 106 cells were added to 100 mm plates for 24h at 37°C, cells were
treated or not treated with 10 mM acetylsalicylic acid (Sigma-Aldrich).
After 24h incubation at 37°C, cells were scraped and collected. Cells
were lysed with RIPA buffer containing protease inhibitors or with
Mitochondrial Protein Isolation Buffer (AMRESCO) containing protease
inhibitors. Protein concentrations were quantified in the same lysis
buffers using the Pierce BSA Protein Assay Kit. Concentrations were
measured at 540 nm.

SDS-PAGE and Western Blot
Proteins were denatured with 2X SDS buffer at 95°C. Samples were
loaded onto 4-15% gradient Mini-PROTEAN TGX Gels. BIO-RAD Precision
Pl us WesternC standards were also included on the gels. Gels were
run in 1x TGS buffer for ~1h at 125V. Proteins were transferred onto
nitrocellulose membranes via the Invitrogen iBlot system. Membranes
were incubated overnight at 4°C in Pierce Fast Western antibody
diluent containing the primary antibody against the protein of
interest. Blots were performed for Arginase I, Arginase II, Ornithine
Decarboxylase (ODC), Ornithine Aminotransferase (OAT), β-Tubulin,
and Cytochrome C Oxidase IV (COXIV). All antibodies were supplied by
Santa Cruz Biotechnology. Blots were washed in PBS-Tween-20
(SigmaAldrich), and then incubated for 10 minutes at 4°C in antibody
diluent containing Fast Western Optimized HRP Reagent and BIO-RAD
Precision Protein StrepTactin-HRP Conjugate. Blots were again washed
in PBS-Tween-20. Blots were visualized using Clarity ECL Western
Substrate (BIO-RAD).

Introduction: Airway remodeling (AR) in asthma is characterized by
increased airway smooth muscle mass, subepithelial fibrosis,
epithelial changes, and increased numbers of fibroblasts and
myofibroblasts [1]. Established AR is resistant to current asthma
therapies and can lead to irreversible airflow limitation, thereby
increasing the severity of asthma [2].
Hypothesis: We hypothesized that L-arginine metabolism is altered in
AR, ultimately affecting collagen synthesis which may be evidenced
by upregulation of expression of genes involved in arginine
metabolism.
Methods: We investigated expressions of key regulatory enzymes in
the arginine pathway: arginase I, arginase II, ODC, and OAT proteins
by Western blot and cell immunochemistry in human lung fibroblast
(HLF) from normal (NHLF) and diseased (DHLF) asthmatic donors.
Results: Positive cell staining signal was observed for arginase I,
arginase II, ODC, and OAT in NHLF and DHLF with or without 24h
acetylsalicylic acid treatment. Only OAT was detected in NHLF and
DHLF via Western blot.
Conclusion: Arginase I, arginase II, ODC, and OAT are present in NHLF
and DHLF with or without acetylsalicylic acid (ASA) treatment as
shown via cell immunochemistry. Levels of protein other than OAT
could not be quantified in NHLF or DHLF via Western blot. Further
testing with Western blotting is needed.

CONCLUSIONS

In both normal and diseased human lung fibroblasts with or without ASA
treatment, arginase I, arginase II, ODC and OAT were detected via cell
immunochemistry. The MitoTracker staining enabled us to compare
localization of mitochondria and localization of proteins of interest.
OAT was mostly detected in mitochondrial NHLF and DHLF protein
fractions by Western blotting, however, arginase I, arginase II, and ODC
were not detected. Further refinement of the Western blot technique is
required in order to provide more accurate quantification of protein
levels of arginase I, arginase II, ODC, and OAT.

Cell Staining
2.5 x 105 cells were added to plate wells containing EtOH-washed
glass coverslips. After 24h, cells were treated or not treated with 10
mM acetylsalicylic acid. After 48h incubation at 37°C, cells were
washed with serum-free DMEM. Cells were then incubated with
MitoTracker Orange CM-H2TMRos (Invitrogen) for 15 min at 37°C. Cells
were then fixed for 30 min at RT with CytoFix (BD). Cells were washed
with 1X PBS and left to sit in PBS ON at 4°C. 1X PermWash (BD) was
then added to cells for 30 min at RT. Primary antibody in PermWash
was added to cells, which were then covered and incubated at 37°C
for 2h. Primary antibodies used were against Arginase I, Arginase II,
ODC, and OAT, and were the same antibodies used for Western blot.
Cells were kept ON at 4°C. Cells were washed with 1X PBS. Cells were
then treated with PermWash and secondary antibody (Invitrogen
AlexaFluor 488) for 2h at 37°C. Cells were washed with 1X PBS. Glass
slides were labelled, and EMS DAPI FluoroGel II was added to the
slides. Coverslips were flipped onto the Fluorogel and sealed with
clear nail polish. Slides were examined using confocal microscopy
utilizing 360 nm, 488 nm, and 554 nm wavelengths to view nuclei,
protein of interest, and mitochondria, respectively.
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Figure 2. Expression of arginase I, arginase II, ODC and OAT in DHLF or NHLF, untreated or treated with 10 mM Acetylsalicylic Acid (ASA) for 24h.
Immunofluorescent detection of the protein shown in green. Nuclei counterstained with 4’6-diamidino-2-phenlindole (DAPI) shown in blue.
Mitochondria counterstained with MitoTracker Orange (CM-H2TMRos). All three stains superimposed (merged).
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